Sample testing device and method
By mixing and heating the blood sample with liquid reagents to form precipitates and separate them, the problem of cumbersome and time-consuming nucleic acid separation steps in the prior art is solved, and efficient and low-cost nucleic acid separation and amplification is achieved, and it is suitable for a variety of samples. Type of detection.
Patent Information
- Application Number
- CN202380022132.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-02-15
- Filing Date
- 2023-02-15
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art when isolating nucleic acids in the blood, the steps are cumbersome, time-consuming and expensive, and conventional methods are incompatible with the amplification program, resulting in low nucleic acid separation efficiency, large sample losses, and difficult to automate and user-friendly.
采用将血液样品与液体试剂混合,加热至特定温度,形成沉淀物,并通过离心或过滤分离,得到上清液用于核酸扩增,简化步骤,减少样品损失,提高效率。该方法包括使用镁和甜菜碱作为添加剂,通过形成沉淀物去除核酸抑制剂,并在无需进一步纯化的情况下直接用于核酸扩增。
The nucleic acid separation process is achieved, efficiency and compatibility is improved, steps and costs are reduced, and it can be automated and user-friendly, and is suitable for nucleic acid detection of various sample types.
Smart Images

Figure CN119096130A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Application No. 63 / 268,047, filed on February 15, 2022, which is incorporated herein by reference in its entirety. Background Art
[0003] Blood naturally contains inhibitors of nucleic acid amplification. It is desirable to separate nucleic acids in the blood from the inhibitors so that the nucleic acids can be amplified and analyzed (eg, using PCR, isothermal and / or other amplification methods).
[0004] Typically, to perform this separation, a blood sample is placed in a lysis / binding solution to lyse the blood and bind it to a separation component, such as magnetic beads and silica resin.
[0005] The lysis / binding solution lyses intact cells in the blood sample, releasing nucleic acids. Typically, lysis solutions are not compatible with amplification procedures. Nucleic acids must be purified from the lysis solution. For example, nucleic acids are bound to silica via magnetic beads, which are then bound to a solid magnetic surface. Unbound inhibitors and other blood components and solutions are then washed with alcohol, typically leaving behind nucleic acids bound to the silica. The bound nucleic acids are then eluted from the silica with an aqueous buffer.
[0006] This achieves nucleic acid separation. However, these steps often inhibit amplification (e.g., PCR), and the alcohol used for washing is volatile. In addition, each washing step results in more steps, expenses, and sample loss. This process of isolating only the nucleic acids of a sample typically takes 30-60 minutes. Magnetic (or other) binding is also not 100% effective, so some target nucleic acids will be washed away. These issues make it difficult, time-consuming, and expensive to automate the process and incorporate a user-friendly device.
[0007] Therefore, a simpler and more effective separation method and supporting device are needed. Summary of the invention
[0008] Methods for separating components of a liquid sample are disclosed. In some embodiments, the method may include mixing the liquid sample with a liquid reagent. In some embodiments, the liquid reagent may include additives for removing inhibitors from a blood sample, reducing the secondary structure of nucleic acids, and adding components required for amplification. These additives may include monovalent cations, divalent cations (including barium, copper [II], calcium, magnesium, manganese [II], zinc, iron [II], nickel, cobalt, tin [II], cadmium, lead), multivalent cations, anions (including sulfate and chloride), naturally occurring or modified amino acids, oligonucleotides, buffer components, and any other additives for increasing amplification yield. In some embodiments, the additives may include magnesium and betaine. The method may include heating the mixed liquid sample and liquid reagent to 70°C to 120°C for 10 seconds to 20 minutes, more narrowly at 80°C to 99°C for 5-10 minutes, or even more narrowly at 85-95°C for 5-10 minutes. These methods may include forming a precipitate when heating the mixed liquid sample and liquid reagent. The method may include centrifuging the heated mixed liquid sample and liquid reagent. The method may include forcing the mixed liquid sample and liquid reagent of heating to pass through a filter. The method may include a liquid reagent mixed with a liquid sample, heated with the liquid sample to form a precipitate, still present in the supernatant after removing the precipitate, and used for subsequent nucleic acid amplification reactions without any further purification, dilution or processing. The method may include exposing the supernatant or filtered solution to a lyophilized or dried reagent, which participates in nucleic acid amplification when it is reconstituted. The nucleic acid amplification method may be isothermal, using multiple thermal steps, or using a thermal cycling scheme. The nucleic acid amplification method may be a strand displacement amplification (SDA). In some embodiments, there is a nucleic acid reporter oligonucleotide containing a detectable portion during the amplification reaction. In some embodiments, a nucleic acid reporter oligonucleotide containing a custom nucleic acid sequence region may be used for detection.
[0009] The liquid sample can be a blood sample. The liquid sample can be an eluate of a swab. The swab sample can be oral, nasal, nasopharyngeal, throat, oral, cheek, skin, lesion, rectum, feces, vagina, urethra. The swab sample can be environmental. The method can include exposing the resulting filtered liquid to a controlled light frequency and sensing the light frequency emitted, absorbed or transmitted from the resulting filtered liquid. In some embodiments, a nucleic acid reporter oligonucleotide comprising a postal code region can be used for detection, and the postal code region comprises a custom nucleic acid sequence region.
[0010] Methods, devices and reagents for separating components of a liquid sample are disclosed. The device may have a housing containing a liquid reagent chamber, an inlet port for receiving a liquid sample, a processing chamber for mixing and heating the liquid sample and reagent, a processing chamber heater, a processing chamber outlet valve, a processed sample filter, a detection chamber, an optical sensor adjacent to the detection chamber; and a light emitter adjacent to the detection chamber. Part or all of the detection chamber may be transparent. The liquid reagent chamber may be at least partially or completely filled with a liquid reagent containing magnesium or betaine or both. The device may have a gas permeable membrane on the detection chamber to allow liquid transport.
[0011] The device may be a self-contained device having all components for performing analytical tests, including detection, heating, sensing, calculation, power supply, display and / or wireless transmission. The device may comprise one or more circuit boards or flexible boards or a combination thereof.
[0012] The device can be powered by battery or solar or USB connection or wireless power induction or any external power source.
[0013] Nucleic acid reporter oligonucleotides are disclosed that can be added to amplification reactions to allow multiple detection of nucleic acid targets. In some embodiments, the reporter oligonucleotide can include a postal code region labeled with a detectable label that is complementary to an oligonucleotide capture probe that can be exposed to the reaction. During the reaction, in the presence of a desired target, the single-stranded postal code sequence can be released from the reporter molecule and can then hybridize with the oligonucleotide capture probe and be detected or form another complex to initiate another event or detection mechanism. The oligonucleotide capture probe can be on a surface or in a solution. The surface can be flat or spherical. The capture probe can be located in a capture probe array. The complex can be an oligonucleotide-oligonucleotide complex, wherein one or more oligonucleotides can include non-naturally occurring nucleotides. The complex can be an oligonucleotide-protein complex, wherein the protein can be an enzyme or a non-enzyme protein. The oligonucleotide-protein complex can include double-stranded or single-stranded oligonucleotides. The complex can initiate other biochemical or reporting processes, such as chain-specific cleavage of nucleic acids or enzyme signal amplification. The complex can initiate a nucleic acid amplification event. The label on the postal code region can be detected using a low-cost, low-power method.
[0014] A method for separating components of a liquid sample is disclosed. The method may include mixing the liquid sample with a reagent, heating the mixed liquid sample and liquid reagent from about 80° C. to about 99° C., and separating the resulting precipitate from the liquid supernatant. The reagent may have a divalent cation. The reagent may be a liquid reagent or have a liquid reagent. The reagent may be a dry reagent or have a dry reagent. The precipitate may be separated from the liquid supernatant by centrifugation. The precipitate may be separated from the liquid supernatant by forcing the heated mixed liquid sample and liquid reagent through a filter. The liquid sample may have a blood sample. The divalent cation may be magnesium. The liquid reagent may have betaine. The heating may be continued for at least 10 seconds. The heating may be continued at about 95° C. for at least or exactly 5 minutes.
[0015] The method may include exposing the resulting filtered liquid to a controlled light frequency and sensing the light frequency emitted, absorbed or transmitted from the resulting filtered liquid.
[0016] The resulting precipitate can remove nucleic acid inhibitors from the liquid supernatant. The method can include performing nucleic acid amplification on the liquid supernatant. The method can include detecting the presence of nucleic acids by fluorescence, absorbance, electrochemical detection, or a combination thereof. The method can include performing nucleic acid amplification on the liquid supernatant without further dilution.
[0017] A device for separating components of a liquid sample is disclosed. The device may have a reagent chamber containing a reagent, an inlet port for receiving the liquid sample, a processing chamber, a processing chamber heater, a processing chamber outlet valve, a processed sample filter, a detection chamber, an optical sensor adjacent to the detection chamber, or a combination thereof. The reagent may have a divalent cation. The detection chamber may be at least partially transparent. The device may include a light emitter adjacent to the detection chamber. The liquid sample may have a blood sample. The divalent cation may be magnesium. The liquid reagent may have betaine. The heating may last for at least 10 seconds. The device may have a detection chamber membrane on the detection chamber. The reagent may be a liquid reagent. The reagent may be a dry reagent.
[0018] A system for separating components of a liquid sample is disclosed. The system can have a reagent chamber containing a reagent, an inlet port for receiving the liquid sample, a processing chamber, a processing chamber heater, a processing chamber outlet valve, a processed sample filter, a detection chamber, an optical sensor adjacent to the detection chamber, a light emitter adjacent to the detection chamber, or a combination thereof. The reagent can have a divalent cation. The detection chamber can be at least partially transparent.
[0019] The liquid sample may be a blood sample. The divalent cation may be magnesium. The liquid reagent may have betaine. The heating may last for at least 10 seconds.
[0020] The system may have a detection chamber membrane on the detection chamber. The reagent may be or have a liquid reagent. The reagent may or have a dry reagent.
[0021] A reporter oligonucleotide is disclosed. The reporter oligonucleotide can indicate the presence of a target nucleic acid in a sample, wherein due to the presence of the target, a portion of the reporter oligonucleotide acquires the ability to hybridize with a non-target specific oligonucleotide capture probe. The reporter oligonucleotide can include a sequence specific to the target nucleic acid, a recognition sequence for a restriction enzyme, a polymerase extension blocker, a sequence specific to the oligonucleotide, and a combination thereof. The reporter oligonucleotide can have a secondary structure to prevent hybridization with the oligonucleotide capture probe in the absence of the target. The portion of the reporter oligonucleotide complementary to the oligonucleotide capture probe can be cut from the reporter oligonucleotide by the reaction of a restriction enzyme.
[0022] The oligonucleotide capture probe can be attached to an electrochemical detection surface. The presence of the hybridized portion of the reporter oligonucleotide can be detected electrochemically. Portions of the reporter oligonucleotide have a label that can be detected using any of fluorescence, fluorescence lifetime, chemiluminescence, colorimetry, gravimetry, cantilever, surface plasmon resonance, or a combination thereof.
[0023] The oligonucleotide capture probe can be attached to a surface. The oligonucleotide capture probe can be attached to a bead. The oligonucleotide capture probe can be suspended in a solution. The reporter oligonucleotide can be a reactant in a nucleic acid amplification reaction in the presence of a target.
[0024] In the presence of the target, the reporter oligonucleotide can be a reactant in an isothermal nucleic acid amplification reaction. The isothermal nucleic acid amplification can have a thermal step to bring the temperature to a different level than when the isothermal reaction occurs. In the presence of the target, the reporter oligonucleotide can be a reactant in a nucleic acid amplification reaction.
[0025] The present invention discloses a system for detecting multiple nucleic acid sequences in a chamber by hybridizing the results of a single sequence to a specific location on the surface of a container. A single sequence strand or representation of a strand can have a fluorescent label using fluorescence lifetime measurement.
[0026] The present invention discloses a system for detecting multiple nucleic acid sequences in a chamber by hybridizing the results of a single sequence to one or more beads in a container. A single sequence strand or representation of a strand can have a fluorescent label using fluorescence lifetime measurement.
[0027] The present invention discloses a system for detecting fluorescence within a chamber by using a fluorescent tag that is measured using fluorescence lifetime. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 A variation of this arrangement is shown.
[0029] Figure 2 Variants of micropipettes are shown.
[0030] Figure 3a and Figure 3b A computer-aided design and a schematic cross-sectional view of a portion of a variant of the device, respectively.
[0031] Figure 3c is a perspective view of part of the device with the cap open.
[0032] Figure 4a and Figure 4b Partial perspective side view and top view, respectively, of a portion of a variant of the device with the cap open.
[0033] Figure 4c is a perspective view of a portion of a variant of the device with the cap open.
[0034] Figure 5a and Figure 5b When the cap is closed Figure 4a and Figure 4b Partial perspective side view and top view of parts of a variant of the device.
[0035] Figure 6a is a perspective view of the detection system.
[0036] Figure 6b is a close up view of a portion of a variation of a fluid system assembly.
[0037] Figure 7 is a schematic cross-sectional view of a variation of the device.
[0038] Figure 8 is a schematic cross-sectional view of a variation of the device.
[0039] Fig. 9 is a schematic cross-sectional view of a device variant.
[0040] Fig.10 is a schematic cross-sectional view of a device variant.
[0041] Fig.11 is a schematic cross-sectional view of a device variant.
[0042] Fig.12 is a schematic cross-sectional view of a device variant.
[0043] Fig.13 A flow chart outlining a typical assay for whole blood samples is shown.
[0044] Fig.14a and Fig.14bPossible control oligonucleotide configurations are shown.
[0045] Fig.15a is a graph showing the dependence of the precipitation reaction on the magnesium concentration.
[0046] Fig.15b Shows the Fig.15a Sample results for Fig.
[0047] Fig.16 A variation of the system is shown in which heating, sensing, and fluid manipulation are performed by instrumentation external to the device.
[0048] Fig.17 A variation of the locking cap for the input port is shown.
[0049] Fig.18 A variation of the system is shown in which an external collection bottle is used to load the sample into the device.
[0050] Fig.19a and Fig.19b A variation of the device is shown with a liquid reagent present in the input port.
[0051] Fig. 20 A variation of the system for loading samples from swabs is shown.
[0052] Fig.21 Device variations with multiple detection chambers are shown.
[0053] Fig.22a and Figure 22b An example of a device designed for fluid manipulation using centrifugation is shown.
[0054] Fig.23 An embodiment of a pierceable membrane valve is shown.
[0055] Fig.24 The general structure of the reporter oligonucleotide is shown.
[0056] Fig.25 The epifluorescence detection setup is shown.
[0057] Fig.26 The time-resolved fluorescence detection setup is shown.
[0058] Fig. 27 A more compact and lower-cost time-resolved fluorescence detection setup is shown.
[0059] Fig.28 A minimal time-resolved fluorescence detection setup is shown.
[0060] Fig.29 A temporal diagram of the time-resolved fluorescence detection step is shown.
[0061] Fig.30 Electrochemical interrogation of positive and negative amplification reactions is shown. DETAILED DESCRIPTION
[0062] Figure 1 An embodiment of a device 610 is shown having a hard shell 613. The shell may have openings for one or more displays 614, access ports 611, communication ports 615, or a combination thereof. The display may be an LCD, E-Ink, LED display, one or more LED indicators, or any technology that can convey visual information.
[0063] The device may have an inlet port for receiving a liquid sample to be tested. The device may have a cover, seal, lid or cap 612 for closing and sealing the inlet port. Fig.17 As shown, the cap can be configured to activate the device (e.g., sample nucleic acid separation and analysis). The cap can be attached to the inlet port and / or adjacent to the inlet port, such as by a flexible band. The cap 612 and the inlet port 611 can be snap-fitted. The cap can have a cap closure projection 647. The shell can have a cap closure port. When the cap is in a closed configuration, the cap closure projection 647 can be translated into the cap closure port. The cap closure projection 647 can have teeth 772, and the teeth 772 match the pawl feature 771 on the inlet port to prevent the cap from opening once closed. The cap closure projection 647 can press a button or switch or feature in the cap closure port, which can mechanically activate the device and then send a signal (e.g., send to a processor) in the device, indicating that the cap 612 is closed and the inlet port 611 is sealed. In some embodiments, the cap 612 and the inlet port 611 can be connected by a living hinge 773.
[0064] The device can have more than one inlet port 611 so that one device 610 can process multiple samples, for example, if testing for STDs, both a swab sample and a blood sample may be needed. A device with more than one inlet port 611 can have multiple separate liquid paths with separate filters and separate membranes and separate detection chambers. A device with more than one inlet port 611 can have multiple reagent chambers, or it can share one or more reagent chambers with different inlet ports 611. A device with multiple inlet ports 611 can be configured so that samples in different inlet ports 611 are processed simultaneously or samples are processed at different times, for example, if one device is used to test samples from different people.
[0065] The inlet port may be a capillary channel or chamber, wherein sample deposition is aided by capillary forces from the channel or chamber. The channel or chamber may be coated with a hydrophilic coating to aid in the deposition of the sample. The inlet port may have a cap, or may not have a cap, or may have a pierceable membrane, such as a rubber septum or other type of membrane. The inlet port may be in a vacuum state so that the sample is drawn into the fluid structure.
[0066] The system can be composed of a disposable cartridge 762 containing dry and liquid reagents, membranes, filters, wherein the disposable cartridge is coupled with an instrument that can provide some or all of the process drive (e.g., heating, fluid release, and detection circuitry), wherein the detection circuitry can be an optical component or an electrical interface to an electrochemical detection chamber in the consumable cartridge. Fig.16 An exemplary device 760 is shown, wherein heaters 626a, 626b, 626c, optical detection 660 and fluid drive are located in instrument 761 together with display 614, power supply (not shown), microprocessor (not shown) and other circuits; wherein disposable box 762 interfaces with the instrument and contains all dry reagents and liquid reagents, (one or more) filters and (one or more) membranes. If the liquid reagent is released in a controlled manner, for example, if the liquid reagent is released by actuator 763, the actuator 763 can be controlled to provide a specific amount of fluid in a specific order, then valves may not be required.
[0067] The communication port may have one or more plug sockets and / or wireless (eg, Bluetooth, Wifi, NFC, infrared, or any other wireless communication protocol) receiving and transmitting components.
[0068] Figure 2 A variation of a micropipette 620 is shown that can be used to deliver a droplet of a liquid sample from a pipette port 621 into or through the inlet port 611 .
[0069] Figure 3a to Figure 3c It is shown that inside the housing, the device can have a fluid structure 630, for example, for the sample to flow through during separation and / or analysis. The device can have an actuation structure, for example, to trigger and actuate the device to perform separation and / or analysis of the sample. The actuation structure can have a spring-loaded syringe. The actuation structure can be actuated by closing the cap 612. Part of the fluid structure 631 includes an inlet port, a processing chamber, a filter, and a detection chamber.
[0070] The device can have an actuator 639. The device can have an actuator spring 638, such as a coil spring, which can be compressed before the device is actuated (e.g., before the cap 612 is closed). The actuator 639 can be in contact with and / or attached to the actuator spring 638. The actuator 639 and / or the actuator spring 638 can be located in a chamber and / or on a guide rail, which can limit movement to a one-dimensional linear translation, for example, parallel to the longitudinal axis of the device.
[0071] The device may have a reagent chamber 634 that may be partially or completely filled with a flowable reagent (referred to herein as a "liquid reagent" and a "diluent," but the reagent may be reactive and / or diluent and have a liquid, solid (e.g., powder), and / or gas) prior to actuation of the device. The liquid reagent may include magnesium, betaine, or a combination thereof.
[0072] An anticoagulant may be added to the inlet port 611 of the device or to the applicator or external collection bottle or any other part of the device or system to prevent blood from clotting and thereby hindering the function of the device. The anticoagulant may be dried into the device, coated on the wall, powdered or provided as a lyophilized material in the device. Anticoagulants that may be considered for use are sodium heparin, lithium heparin, dipotassium EDTA, tripotassium EDTA, sodium citrate, ACD (sodium citrate, citric acid, glucose, potassium sorbate), CTDA (sodium citrate, theophylline, dipyridamole, adenosine), fluoride / oxalate, fluoride / EDTA or any other combination of one or more of the materials that prevent blood flow.
[0073] The reagent chamber 634 can be adjacent to the actuator 639. The reagent chamber 634 can have a plunger 629 that can span the height of the reagent chamber and can have a fluid seal with the inner wall of the reagent chamber. The plunger can slide in the reagent chamber. Before the device is started, the plunger can be adjacent to the actuator 639. The plunger can be separated from the actuator by the actuator seal 628b. The actuator 639 can have a sharp tip that can be configured to pierce the actuator seal 628b.
[0074] Liquid reagents can be released using a spring force released by closing of the inlet cap 612. The system can use compressed gas instead of mechanical spring force. Liquid reagents can be released by manual activation by the user of the device. Liquid reagents can be released by an actuator.
[0075] The reagent chamber can have a pressure-sensitive valve and / or a reagent chamber seal 628a on the outlet channel relative to the plunger. When the actuator spring is in an expanded configuration, the actuator can press a liquid reagent, such as increasing the pressure in the reagent chamber 634, enough to open the valve or destroy the reagent chamber seal 628a. The plunger can partially or completely translate through the reagent chamber, and some or all of the reagent is pushed out of the reagent chamber by the valve or the reagent chamber seal of the destruction. The reagent chamber can have a valve between the reagent chamber and the inlet port 611, and the valve can be any type of valve. The reagent chamber seal 628a can be destroyed by the reagent chamber piercing port 625 that is connected with the inlet port 611 fluids.
[0076] The inlet port 611 may be partially or completely conical, with the tip of the cone pointing downward. When the cap 612 is opened, the sample 637 may be dripped into the inlet port 611 , for example, from a micropipette 620 .
[0077] Fig.18 An exemplary embodiment of a system 780 is shown where the device 610 can use an external collection bottle 781 which can contain the chemical components needed for the separation process, and the external collection bottle 781 can contain liquid reagents. The external collection bottle can receive a swab or blood sample or other sample type.
[0078] The sample may be introduced into the reagents in a separate device, such as a blood collection applicator (eg, a capillary tube or pipette) or an external collection vial 781 or absorbent pad may be coated or soaked with one or more blood separation reagents.
[0079] The reagent chamber 634 may be in fluid communication with the inlet port 611 when the reagent chamber seal 628a is ruptured and / or a valve on the reagent chamber is opened.
[0080] The inlet port and reagent chamber may be combined into one chamber containing liquid reagents and / or dry reagents into which the user introduces the sample.
[0081] Fig.19a An embodiment of the device 790 is shown in which the inlet port 611 contains a diluent or liquid reagent 795 and the valve 792 is activated once the cap is closed.
[0082] Fig.19b An embodiment of the device 791 is shown in which the inlet port 611 contains a diluent or liquid reagent 795 and the liquid in the inlet port is pushed into the reaction chamber once the lid is closed using a seal 793, which can be broken through a piercing port 794, which can be pierced by the force of a spring 795 or other means.
[0083] The inlet port 611 may be configured so that a swab may be inserted directly into the inlet port, and optionally left in the inlet port during processing. Some swabs are made to be snap-off, which allows the cap to be closed with the swab inside the inlet port. Fig. 20 An embodiment of system 800 is shown in which a swab 801 is inserted into the inlet port of device 610; in one embodiment, the swab is removed before the lid is closed, and in another embodiment, the swab handle is broken off and the swab remains in the device when the lid is closed.
[0084] The inlet port 611 can be in fluid communication with the processing chamber 632. When the cap 612 is closed, the actuator 639 can be triggered or actuated to push the liquid reagent into and through the inlet port 611, mix the liquid reagent with the sample 637, and press the mixed liquid reagent and sample into the processing chamber 632. The processing chamber 632 can include a gas permeable processing chamber membrane 627a to allow trapped air to escape when the liquid moves into the processing chamber 632.
[0085] The apparatus can have a process chamber heater 626a located within or adjacent to (e.g., within or in contact with) the process chamber 632. The process chamber heater 626a can, for example, heat the mixed sample and liquid reagent to 70°C to 120°C for 10 seconds to 20 minutes, more narrowly at 80°C to 99°C for 5-10 minutes, or even more narrowly at 85-95°C for 5-10 minutes.
[0086] The heater can be any type of technology that generates heat. An embodiment is a resistive heater, such as one or more conductive heating traces or heating wires, adjacent to the area to be heated or a conductive sheet or pad or resistor. Portions of the fluid structure can be made of conductive materials that can heat when exposed to electric current. The heater can be a hot fluid, such as hot air or hot liquid, flowing near the area to be heated. The heater can use Joule heating of the actual fluid in the device by applying an electric current through the fluid through direct contact or capacitive contact. The heater can be an infrared heater. The heater can be one or more semiconductor devices, such as a field effect transistor bipolar junction transistor (bjt) transistor or a diode or other semiconductor device, wherein heating is generated by power dissipation in such semiconductor devices. Heat may be generated by a chemical reaction, either by the fluid in the device reacting with a reagent, or by an exothermic reaction of a material outside the fluid in the device. The heater can be a wireless heater that dissipates heat directly into the fluid in the device or into some other material in or near the device. The heater can be any combination of heating technologies.
[0087] The processing chamber may have an actuatable processing chamber outlet valve 636 or seal (collectively referred to herein as a processing chamber outlet valve). The processing chamber outlet valve may be an electromechanically actuated valve, such as a solenoid valve, a thermostat connected to a mechanical valve configured to open at a preselected temperature (e.g., about 92°C to about 98°C, such as 95°C), an osmotic pump, a wax valve, an actuatable plastic valve, a low melting point metal valve, a membrane or paper barrier or a chemical valve (e.g., a soluble sugar), or any other barrier that allows fluid connection once a preselected temperature or time is reached. The device may have a processing chamber valve heater 626b that is adjacent to the processing chamber valve 636. The processing chamber heater may be configured to heat the processing chamber valve to open the processing chamber valve (e.g., melt the wax valve or membrane), for example, for about 5 minutes. In some embodiments, a separate processing chamber valve heater may be used to open the valve.
[0088] The valve may be a wax valve, wherein the valve blocks fluid flow until heat is applied to or near the wax, causing the wax to melt or rupture, thereby opening a passage for the fluid. In addition to wax, it may be any other type of material that melts at a lower temperature than the other materials surrounding the valve; such a material may be a low temperature metal, such as field metal, or another polymer, such as polycaprolactone or polyethylene. The valve may be a pinch valve. The valve may use electroosmosis; for example, the valve may be an electroosmotic pump. As Fig.23 As shown, valve 830 may include a pierceable membrane 831 activated by a force, which may be entered from outside the fluid structure by using a flexible barrier, wherein a force 835 may be transmitted from outside the fluid structure to a needle 832 attached to a flexible arm 833 by a flexible cover 834, and the needle pierces the pierceable membrane 831. After the membrane is pierced, liquid may flow from a valve inlet 836 to a valve outlet 837. The valve may be activated by heat from a heater, mechanical force from a solenoid or motor, manual means from a user, a bimetallic actuator, or deformation of, for example, nitinol, or any other means or actuator. A thermosensitive process chamber valve (e.g., a wax valve or membrane) may be used without a process chamber valve heater. For example, when a mixed sample and a liquid reagent reach the correct temperature in the process chamber 632, the heat of the mixed sample and the liquid reagent may open the thermosensitive process chamber valve (e.g., melt or destroy the wax valve or membrane).
[0089] When the process chamber valve is opened, the mixed sample and liquid reagent may be under pressure. For example, the actuator spring pressed on the plunger by the actuator may still be in a partially compressed position, and the plunger may still be free (i.e., unimpeded) to travel toward the reagent chamber seal in the reagent chamber.
[0090] The device can have a detection chamber 633 and a processed sample filter 635. The processed sample filter can be located between the processing chamber outlet valve and the detection chamber. When the processing chamber valve is opened, the mixed liquid reagent and sample can flow to and be pressed into the processed sample filter. The processed sample filter can filter out inhibitors and / or other non-nucleic acid components in the blood. The detection chamber 633 can have a detection chamber heater 626c located in or near the detection chamber. The detection chamber can accommodate dry or freeze-dried reagents required for nucleic acid amplification reactions, and the detection chamber 633 can have a breathable membrane 627c covering a portion of the detection chamber area for evacuating air or gas when filling the detection chamber.
[0091] The valve can be a wax valve, where the valve blocks the flow of fluid until heat is applied to the wax or near the wax, causing the wax to melt or rupture, thereby opening the fluid channel. Instead of a wax valve, the valve can be any other type of material that has a melting temperature lower than the melting temperature of other materials around the valve. This material can be a low-temperature metal, such as field metal, or other polymers, such as polycaprolactone or polyethylene. If the liquid reagent is released in a specific volume, a valve may not be needed. For example, if 200ul of liquid reagent is initially released, it may only fill the processing chamber; after the processing chamber heating step, another amount of liquid is released, which pushes the treated liquid through the filter and into the detection chamber. In some embodiments, after the first liquid reagent release fills the processing chamber and the processing chamber heating step is completed, a separate liquid release or gas release is introduced in the device to push the liquid through the filter and into the detection chamber. In some embodiments, after the first liquid reagent release fills the processing chamber and the processing chamber heating step is completed, a separate actuator pushes a flexible or movable member in the device, thereby pushing the liquid through the filter and into the detection chamber. Actuation may be automatic or manual.
[0092] Liquid actions such as valve actuation and fluid movement can be performed using electrowetting on dielectrics or digital microfluidics techniques.
[0093] The device may have a centrifuge. The mixed sample and liquid reagent may be centrifuged to separate the components after leaving the processing chamber and before the resulting liquid is delivered to the processed sample filter and / or directly to the detection chamber.
[0094] Fig.22a and Figure 22bAn exemplary embodiment of a device 820 is shown, which uses centrifugal force and capillary force to centrifuge processed samples and perform fluid movement. Instead of using a filter to remove inhibitors from the fluid or in addition to using a filter to remove inhibitors from the fluid, the fluid can be centrifuged and the supernatant can be further processed in the detection chamber. In this exemplary device, the inlet port 611, the reagent chamber 634, the processing chamber 632 and the detection chamber 633 are located on a disc-like structure 821, wherein a motor 822 inside or outside the device provides a rotational actuation for centrifugation. The rotational action can be provided by the user, for example, the user can pull a rope or press a button, and the button is converted to rotate all or part of the fluid structure. When the lid is closed, the spike 824 pierces the pierceable seal 825, thereby opening the fluid path from the inlet port 611 to the liquid reagent chamber 634 in the center of the disc; the fluid will move from the liquid reagent chamber in the center of the disc to the inlet port 611, and at the inlet port 611, the reagent and blood will further move to the processing chamber 632 under the action of the centrifugal force generated by the rotation of the disc. The sample and reagent mixture in the processing chamber can be passively or actively mixed and heated by the movement of the disk, after which the disk will rotate to centrifuge and separate dense sample components 826, such as unwanted blood components; after centrifugation, when the disk is in a non-rotating or slow-rotating state, the outlet capillary channel 823 from the processing chamber will be filled; thereafter the disk will rotate to siphon the upper supernatant in the processing chamber to the detection chamber for amplification and detection. The device can have a detection chamber heater 626c in or near the detection chamber 633 (e.g., in or in contact with the wall of the detection chamber 633).
[0095] The detection chamber may be covered with a gas permeable detection chamber membrane 627b.
[0096] The breathable membrane is used to exhaust the fluid in the device and remove the gas from the fluid in the device, and can be added to the device by heat sealing, ultrasonic welding, adhesives, insert molding or any other method of adding materials to injection molded parts. The membrane can be made of one or a combination of the following materials: PTFE, polypropylene, nylon, polyethersulfone, polyvinylidene fluoride, polytetrafluoroethylene, polycarbonate, polyethylene, low-density polyethylene or any other material that can exhaust air and degas the fluid. The pore size of the exhaust membrane can range from 0.02 microns to 5.0 microns. The membrane can be hydrophobic and / or hydrophobic and oleophobic. The flow rate of the exhaust air ranges from 0.1 slmp (standard liters per minute) to more than 2 slmp.
[0097] Figures 4a to 4cAn exemplary device 640 is shown having an actuation arm 645. The actuation arm may rotate about an actuation pivot 646. The actuation arm may have an arm protrusion 644 that may extend radially inward from the remainder of the actuation arm at the end of the arm toward the actuator.
[0098] The actuator may have an actuator protrusion 642 extending transversely from the longitudinal axis and / or direction of travel of the actuator. The actuator protrusion may have an actuator slot 641. The actuator slot may be shaped and sized to accept an interference fit with the arm protrusion.
[0099] The actuator arm may be in a locked configuration when the cap is open and the cap closure protrusion 647 has not been received by the cap closure port 648. The actuator spring 638 may be fully or partially compressed and the arm protrusion may be seated in the actuator slot, e.g., interference fit and preventing the actuator from translating.
[0100] The reagent chamber 634 can be enclosed in the reagent chamber housing 643 and contain liquid reagents for the sample. In some embodiments, the device can have a separate reagent chamber that can contain liquid reagents.
[0101] Figure 5a and Figure 5b An embodiment of the device is shown, wherein when the cap 650 is closed, the actuator can be moved to an unlocked configuration. When the cap closure projection 647 is inserted into the cap closure port 648, the translation of the cap closure projection (as shown by arrow 653) can push down the end of the actuator arm closer to the fluid structure. The actuator arm can rotate around the actuation pivot (as shown by arrow 652). The end of the actuator arm near the arm projection can be translated upward, as shown by arrow 651, the arm projection is moved out of the actuator slot, the actuator is released to translate slidably, as shown by arrow 654, the plunger is pressed into the liquid reagent, the reagent chamber outlet seal is opened, and the liquid reagent is pushed into the inlet port, thereby pushing the mixed sample and the liquid reagent into and through the fluid structure.
[0102] Translation of the cap closure tab and / or rotation of the actuator arm may close a switch and / or press a button to activate the heater and detection chamber components (e.g., sensors and LEDs). Liquid may be sensed using a capacitive sensor or other methods using a liquid sensor or by optical means or by initiating heating and further processing steps directly or indirectly through a microprocessor.
[0103] Figure 6a and Figure 6b Embodiments of devices that may have one or more optical sensors are shown. Figure 6ais an end view of the detection system 660 showing the optical sensor 664, the first LED 662 and the second LED 663 in the metal sleeve 665. Variations of the detection chamber and adjacent elements of the device. Figure 6b A close-up view of a portion of a variation of a fluid system assembly 661 showing a detection chamber 633 with a detection system 660 .
[0104] In some embodiments, the detection chamber may have holes or features in its walls in which the optical sensor is located.
[0105] The device can have a first LED 662 and a second LED 663 on opposite sides of the detection chamber. From the top, the LED can be positioned 90 ° away from the optical sensor relative to the detection chamber. The detection chamber can be completely or partially (e.g., three positions near the LED and the optical sensor) translucent or transparent. In other embodiments, the optical sensor can be placed on the side of the detection chamber adjacent to or opposite to or the same as the LED. The detection chamber 633 can be located in or near a thermally conductive sleeve 665, such as a metal sleeve or a thermally conductive polymer sleeve, for distributing heat around the detection chamber. The sleeve can accommodate an optical detector 664, LED 662, and LED 663.
[0106] Fig.21 An embodiment of a device 810 is shown, where the device may include more than one detection chamber, such as a first detection chamber 633a and a second detection chamber 633b, such that the liquid is divided into 1, 2, or more detection chambers after the filter 635, which may increase the number of test targets that can be detected by the device and / or provide confirmation of one or more results if one or more results are repeated in more than one detection chamber. In another embodiment, the device may not include a detection chamber, but rather the processed sample is extracted from the device for further processing or detection outside the device.
[0107] In some embodiments, the device may have one or more digital processors or microprocessors and memory chips, such as on a circuit board. The optical sensor may communicate data with the microprocessor and / or onboard memory, and (possibly via the microprocessor and / or memory) with a display and / or a communication port. The data results from the optical sensor after sample processing may be analyzed and / or digitally processed by the microprocessor in the device, displayed on a display and / or transmitted to another device, such as a smartphone, a computer, or any other device other than a device that can receive wireless transmissions, via a communication port and / or other wireless transmitters in the device.
[0108] An application on a smartphone or computer or any other computing device may interact with the device, thereby receiving data generated by the device. The application may collect other data, such as operator identification, location, altitude, humidity, sound level, sound recording, date, time, temperature, sample identification. If the sample is from an animal or human, the application may collect identification information of such animal or human. The application may obtain an image of the animal or human and / or the location of sample collection. The data from the device and other data may be stored on the smartphone or computer or any other computing device and / or may be further transmitted to another database, such as a cloud storage solution. The application may also transmit data or instructions to the device to guide the processing steps. The application may calculate the final result of the test. The application may operate in such a way that the test results from the device may not be readily available to the test operator, but the data may be transmitted to another database or computing system, and the test results may be available to the user only after approval by another entity. The application may operate in such a way that the test results from the device may not be readily available to the test operator until a certain time has passed. The application may operate in such a way that the test results from the device may not be readily available to the test operator until the application detects a change in location. The application can obtain other data to add to the stored data related to the specific test, such as weather conditions, location characteristics, environmental characteristics (such as traffic or lighting conditions or pollution or infection levels), or any other data that can be collected from other databases or websites.
[0109] An application on a smartphone or computer or any other computing device that can interface with the device can initiate the start of sample processing and / or the application can initiate the end of sample processing after a predetermined time or if it is determined that enough data has been received to determine the result or an error has been detected.
[0110] Software in the device may end sample processing after a predetermined time or if it determines that enough data has been received to determine a result or an error has been detected.
[0111] The sample processing chamber and / or the detection chamber may have additional dry and / or liquid reagents, which may be the same or different from the liquid reagents in the reagent chamber. In one embodiment, the device does not contain any liquid reagents, but only dry reagents, which are mixed with the sample before or at the beginning of processing the sample.
[0112] Figure 7The embodiment of device 670 without dedicated sample processing chamber is shown. Mixing and heating of sample 637 and liquid reagent can occur in inlet port 611. The device can have an inlet port heater, which can be configured as a processing chamber heater 626a as described herein. The device can have an inlet port outlet valve, which can be configured as a processing chamber outlet valve 636 as described herein. The device can have an inlet port outlet valve heater, which can be configured as a processing chamber outlet valve heater 626b as described herein. When the inlet port outlet valve is opened, the inlet port can be in communication with the processed sample filter fluid. Cap 612 can have a cap gas permeable membrane 627c.
[0113] Figure 8 An exemplary device 680 without a process chamber outlet valve and / or a process chamber outlet valve heater is shown. The process chamber may be in fluid communication with the processed sample filter through a channel restriction. The channel restriction may be a narrowing of a conduit between the process chamber and the processed sample filter.
[0114] Fig. 9 An exemplary device 690 is shown where the cap and / or detection chamber may have a gas permeable membrane. The process chamber may be a channel or have a channel, such as a tube 691. The process chamber heater may be coiled around the tube of the process chamber, integrated into the tube (e.g., in the tube wall), or a combination thereof.
[0115] Fig.10 An exemplary device 700 without a processing chamber outlet valve and / or a processing chamber outlet valve heater is shown. The processing chamber can be in direct fluid communication with the processed sample filter (e.g., without passing through the processing chamber outlet valve). The processed sample filter can be a breathable membrane or other membrane that allows certain fluids to pass under certain conditions (e.g., high temperature and / or high pressure and / or time and / or fluid type). The detection chamber can be a breathable membrane or have a breathable membrane. The cap can be a breathable membrane or have a breathable membrane.
[0116] Fig.11 An exemplary device 710 without a processing chamber outlet valve and / or a processing chamber outlet valve heater is shown. The sample processing chamber can be combined with the detection chamber. A single main chamber can be separated between the sample processing chamber and the detection chamber by a processed sample filter. The main chamber can have a detection chamber heater on the detection chamber side of the main chamber. The processing chamber heater can be located on a different side of the main chamber from the detection chamber heater.
[0117] Fig.12Embodiment 720 is shown, wherein reagent chamber can have blister pack 721.Reagent chamber can be in chamber or on track and can translate in the housing of device.Actuator can be the flat plate that is attached to the end of actuator spring or contacts with the end of actuator spring.Reagent chamber seal can be the rupturable film 722 (for example foil) on blister pack.When actuator is actuated, actuator can promote reagent chamber and translate it in piercing nozzle.Piercing nozzle can be communicated with inlet port fluid.When reagent chamber translates in piercing nozzle, piercing nozzle can pierce reagent chamber seal.Blister pack can be fixed on fluid structure, and can destroy rupturable seal 722 by promoting the other side of blister pack 721, thereby set up pressure in blister pack 721 inside, and pressure causes rupturable seal 722 to be deformed to the degree of engagement with piercing nozzle, and forms the fluid path from liquid reagent 795 in foil pack to inlet port 611.
[0118] The actuator side of the reagent chamber can be flexible. The blister pack 721 or the reagent chamber can be fixed in the housing. The actuator can press and flatten the actuator side of the reagent chamber, thereby increasing the pressure in the reagent chamber, for example, causing the reagent chamber seal to rupture (for example, whether pierced by the piercing nozzle).
[0119] Amplification reagents (oligonucleotides, enzymes, dNTPs and buffer components) can be lyophilized or dried within the fluid structure so that they can last for a longer period of time at room temperature, and then when the reaction is about to occur, the dried or lyophilized reagents will be reconstituted with the liquid reagents. In order to keep certain reagents active for a longer period of time, they are dried or lyophilized in the device, and as long as they remain dry, they will remain active, so it is necessary to separate the liquid reagents from the dried or lyophilized reagents, which is achieved by containing the liquid reagents in a low liquid permeability material (such as metal foil and / or plastic or other material). The entire device can be packaged in a metal foil bag, which also contains a desiccant to absorb any liquid that may migrate from the outside of the metal foil bag or the liquid reagent chamber.
[0120] Fig.13 A typical assay flow for a whole blood sample is shown. A whole blood sample can be mixed with a liquid reagent 731 containing magnesium ions and all other heat-stable amplification reaction reagents. The liquid reagent can include 3mM to 5mM magnesium sulfate, a Tris buffer of pH 8.8, 0.5M betaine, and oligonucleotides. The sample can be heated 732 to preferably above 85 degrees Celsius and last for 5 minutes or longer, and then the sample can be filtered or centrifuged 733 to separate the precipitate. The remaining supernatant can be combined with a freeze-dried or dried enzyme or other reaction components. Nucleic acid amplification and / or detection events 734 can then occur.
[0121] Figure 14 shows possible control oligonucleotide configurations that can be designed to control reaction feasibility without having to perform a full control amplification reaction, which would take up valuable reaction resources when multiplexing. Fig.14a Design 740 is shown, comprising a control oligonucleotide having a region 744 complementary to a complementary oligonucleotide 742, a region comprising a restriction enzyme recognition sequence 747 separating a fluorophore 746 and a fluorescence quencher 745. The design may include a 3' extension blocker 738. In the presence of viable nucleic acid amplification reactants and reaction conditions, the complementary oligonucleotide may be extended in region 743 to form a double-stranded region comprising a restriction enzyme recognition sequence that can be cleaved by the restriction enzyme, thereby resulting in an increase in fluorescence of the fluorophore. Fig.14b The design of a control oligonucleotide 741 is shown that includes a self-complementary loop structure 748, which is a region that includes a restriction enzyme recognition sequence 747 that separates a fluorophore 746 and a fluorescence quencher 745. In the presence of viable nucleic acid amplification reactants and reaction conditions, the three major ends of the control oligonucleotide can extend in region 743 to form a double-stranded region that includes a restriction enzyme recognition sequence, which can be cleaved by the restriction enzyme, thereby resulting in an increase in the fluorescence of the fluorophore.
[0122] FIG15 shows the dependence of precipitate formation on the magnesium concentration in the heated mixed liquid sample and liquid reagent. The magnesium concentration in the liquid reagent varied from 1 mM to 5 mM, and also contained 20 mM Tris buffer, pH 8.8, and 0.5 M betaine. After mixing the liquid blood sample with the liquid reagent, the solution was heated at 95 degrees Celsius for 5 minutes and then centrifuged at 7000 rpm for 3 minutes. The transparency of the resulting supernatant was analyzed using imageJ (NIH) and plotted on Fig.15a and displayed in Fig.15b middle.
[0123] In some embodiments, a detection reagent can include a reporter oligonucleotide. Fig.24An embodiment of a reporter oligonucleotide design 860 is shown. The reporter oligonucleotide comprises a portion of a reporter oligonucleotide 863 complementary to the desired nucleic acid target in the internal region of the amplicon primer site on the 3' end, a restriction enzyme recognition site 862, a polymerase extension blocking site 865, and a portion of a reporter oligonucleotide comprising a zip code region 861 with an optional detectable label 864. During the reaction, the probe can become double-stranded in the region extending the blocker 3' side. This initiates chain cutting at the recognition site and releases the single-stranded zip code region. The zip code region can include a detectable label, allowing the zip code region to be detected in subsequent hybridization-based events (e.g., hybridization with non-target specific oligonucleotide capture probes). The oligonucleotide capture probe can be in a solution. The oligonucleotide capture probe can be on a surface. The surface can be flat or spherical. The surface can be a bead. The surface oligonucleotide capture probe can be a part of an oligonucleotide capture probe array. The surface can be an electrode in an electrochemical cell. The label can be an electrochemical molecule, such as ferrocene or methylene blue, which will participate in electron transfer with the solid phase electrode, or a fluorescent label, which will emit fluorescence under light excitation of the appropriate wavelength. The label can also be a molecule that exhibits electrochemiluminescence properties. The reporter oligonucleotide can contain a secondary structure to prevent part of the reporter oligonucleotide from hybridizing with a non-target specific oligonucleotide capture probe. During the amplification reaction, due to the presence of the target, a part of the reporter oligonucleotide may acquire the ability to hybridize with a non-target specific oligonucleotide capture probe.
[0124] In many applications, it is desirable to be able to perform multiplexed genetic analysis in a low-cost, low-power, rapid manner. Such reporter oligonucleotides can be incorporated into strand displacement, isothermal nucleic acid amplification assays to indicate the presence of a nucleic acid target in these types of requirements. Isothermal amplification can be detected when the cleaved zip code region of the reporter oligonucleotide containing the electroactive tag hybridizes to an oligonucleotide capture probe covalently bound to an electrode or electrode array in an electrochemical cell. When an appropriate potential is applied to the electrode instead of a reference electrode, electrons are transferred between the electroactive tag and the electrode surface to produce a detectable current.
[0125] The system can detect multiple nucleic acid sequences in a cavity by hybridizing the results of a single sequence to a specific location on the surface of the container, where the single sequence strand or representation of the strand has a fluorescent tag measured using fluorescence lifetime. In other embodiments, the system detects multiple nucleic acid sequences in a chamber by hybridizing the results of a single sequence to one or more beads in the container, where the single sequence strand or representation of the strand has a fluorescent tag measured using fluorescence lifetime. In some embodiments, the system detects fluorescence in a chamber by using a fluorescent tag measured using fluorescence lifetime.
[0126] Detection methods may include optical fluorescence detection, light absorbance, light transmittance, light reflectance, electrochemical, electrical, resistive, and any other method for detecting an analytical assay reaction.
[0127] In some applications, it is preferred to use fluorescence detection. In this case, the label on the cleaved ZIP code region is a fluorescent molecule that fluoresces when excited at an appropriate wavelength after hybridization to the surface capture probe or surface capture probe array. Fig.25 An epifluorescence detection setup 100 is shown in which fluorescent spots 102 are measured using conventional fluorescence measurements, where the emission light wavelength is separated from the excitation light wavelength by using an optical filter. The setup 100 can have a component 101 having a sample chamber 113 in which the fluorescent spots 102 are positioned; the sample chamber 113 can have a transparent cover from which light can reach and exit the fluorescent spots 102, or the sample chamber can be uncovered and the light will pass through the liquid surface, or an optical sensor can detect the fluorescent spots through a transparent bottom or transparent sides of the chamber 113. The fluorescence of the various spots can be measured by exposing them to light of a specific wavelength and then measuring the amount of light emitted at another wavelength. This can be used, for example, to measure various hybridized nucleic acid probes to identify specific nucleic acid sequences. Emission light 114 passes through lens 103, which collimates the light, then passes through beam splitter 104 and detection filter 105, which filters out excitation light from light source 110, and then passes through detection lens 106, which focuses the light onto detector array 107 on plate 108. The excitation light comes from light source 110, which can be a light emitting diode or laser diode placed on plate 109, or other types of light sources with appropriate wavelengths. The excitation light then passes through excitation lens 111, which collimates the light, then passes through excitation filter 112 to beam splitter 104, and further through lens 103 to spot 102. Lenses 103, 111, and 106 help collimate the light passing through optical filters 112 and 105 so that the filters work optimally, which is the case for most optical filters, especially optical interference filters. The beam splitter 104 may also work better with collimated light, particularly if the beam splitter 104 is a dichroic interference filter.
[0128] Time-resolved fluorescence measurements can be used to achieve a more compact, lower-cost fluorescence detection module. The label on the cleaved zip code region can be a fluorescent molecule with a fluorescence lifetime suitable for time-resolved measurements, which is excited at an appropriate wavelength after hybridization to a surface capture probe or surface capture probe array. Tris-(2,2'-bipyridyl)ruthenium is an example of such a fluorophore, which can be covalently bound to an oligonucleotide and has a long fluorescence lifetime of several hundred nanoseconds. Fig.26A detection device 200 is shown, in which a fluorescent spot 102 is measured using a fluorescence lifetime, wherein the emission light is separated from the excitation light by time. The device 200 may have a component 101, which has a sample chamber 113, in which a fluorescent spot 102 is arranged, the sample chamber 113 has a transparent cover, from which light can reach the fluorescent spot 102 and come out of the fluorescent spot 102, the sample chamber may also be without a cover, the light will pass through the liquid surface, or an optical sensor may detect the spot through the transparent bottom or transparent side of the chamber 113. The fluorescence of each spot can be measured by exposing each spot to light at a certain time point and then measuring the amount of light emitted at another time point. This assumes that these spots have fluorophores, the fluorescence lifetime of these fluorophores is long enough so that the excitation and detection components can be turned on and off and measured, and this fluorophore can be tris-(2,2'-bipyridine) ruthenium, which has a fluorescence lifetime of several hundred nanoseconds. This can be used, for example, to measure various hybridization nucleic acid probes to identify specific nucleic acid sequences. Emission light 114 passes through lens 103, which collimates the light, and then passes through beam splitter 104 and detection lens 106, which focuses the light onto an array of detectors 107 on board 108. Excitation light comes from light source 110, which can be a light emitting diode or laser diode placed on board 109, or other type of light source with appropriate wavelength and speed to excite fluorescent spots 102. The excitation light then passes through excitation lens 111, which collimates the light, and then reaches beam splitter 104 and further passes through lens 103 to spot 102. Detection module 200 is simpler than module 100 because there are no optical filters 105 and 112. This allows for a more compact and lower cost module.
[0129] In some applications, it is preferable to use a more compact, lower cost fluorescence detection module. Fig. 27A detection device 300 is shown, in which a fluorescent spot 102 is measured using a fluorescence lifetime, wherein the emitted light is separated from the excitation light by time. The device 300 can have a component 101, which has a sample chamber 113, in which the fluorescent spot 102 is located, and the sample chamber 113 has a transparent cover, from which light can pass through to the fluorescent spot 102 and out of the fluorescent spot 102, or the sample chamber can be without a cover, and the light will pass through the liquid surface, or the optical sensor can detect the spot through the transparent bottom or transparent side of the sample chamber 113. By exposing each spot to light at a certain time point and then measuring how much light is emitted at another time point, the fluorescence of each spot can be measured. This assumes that these spots have fluorophores, and the fluorescence lifetime of these fluorophores is long enough to enable the excitation and detection components to be turned on and off and measured, and this fluorophore can be tris (2,2'-bipyridine) ruthenium, which has a fluorescence lifetime of several hundred nanoseconds. For example, this can be used to measure various hybridization nucleic acid probes to identify specific nucleic acid sequences. The emission light 114 passes through lens 103, which is focused onto detector array 107 on board 108. The excitation light comes from light source 110, which can be a light emitting diode or laser diode placed on board 109, or other types of light sources with appropriate wavelength and speed to excite fluorescent spots 102. The excitation light then passes through excitation lens 111, which focuses the excitation light directly onto fluorescent spots 102. Module 300 is a simpler module than module 100 because it does not have optical filters 105 and 112, and therefore does not require lens 106. This simplification further allows the beam splitter 104 to be eliminated. This can achieve a very compact and lower cost module. The module can be further simplified in the case where the sensor array 107 can be positioned so that each detector in the sensor array 107 has a lens and thus lens 103 can be eliminated. The light emitter 110 may project light directly onto the fluorescent spots 102 without the need for a separate lens 111, or the emitter itself may have a lens as part of the component, which is directional. The sensor array 107 may be a photodiode array and / or a 2D image sensor such as a CMOS or CCD with a fast shutter function that can obscure the image sensor when the emitter 110 is on, or the detector array 107 may have a separate shutter. Using fluorescence lifetime may have advantages with respect to background light, as much of the background light will not have a fluorescence lifetime in the same range as the fluorophores being measured.
[0130] Fig.28The simplest detection device 400 is shown, in which the fluorescent spot 102 is measured by using the fluorescence lifetime, where the emission light is separated from the excitation light by time. The device 400 can have a component 101 with a sample chamber 113, wherein the fluorescent spot 102 is located on a transparent surface, and light can be transmitted from the light source 110 to the fluorescent spot 102. The sample chamber 113 has a transparent cover, and the light can pass from the fluorescent spot 102 through the cover. The sample chamber can also be without a cover, and the light will pass through the surface of the liquid, or the optical sensor can detect the spot through the transparent bottom or transparent side of the chamber 113. The excitation light and the emission light can be exposed and detected from the same side of the chamber 113 or from opposite sides of the chamber 113. The spot 102 can be located on an open surface when reading, and the spot can be in the surrounding liquid or in a nearly dry environment when reading. The fluorescence of each spot can be measured by exposing each spot to light at a certain time point and then measuring the amount of light emitted at another time point. This assumes that the spots have fluorophores that have a fluorescence lifetime long enough for the excitation and detection components to be turned on and off and measured, such a fluorophore could be tris-(2,2'-bipyridyl)ruthenium, which has a fluorescence lifetime of a few hundred nanoseconds. This could be used, for example, to measure various hybridized nucleic acid probes to identify specific nucleic acid sequences. The emitted light is captured onto a detector array 107 with individual lenses on a plate 108. The excitation light comes from a light source 110, which could be a light emitting diode or laser diode placed on a plate 109, or other type of light source with the appropriate wavelength and speed to excite the fluorescent spots 102. The excitation light then passes through the lower portion of a chamber 113 and onto the fluorescent spots 102. The light source 110 could be lensless, or have a built-in lens or a separate lens to direct more light onto the fluorescent spots 102. Module 400 is a simpler module than module 100 because it does not have optical filters 105 and 112 or beam splitter 104, and has fewer lenses. This allows for a very compact and lower cost module. The sensor or detector array 107 can be an array of photodiodes or phototransistors, other light-sensitive elements, a 2D image sensor (such as a CMOS or CCD with a fast shutter function that darkens the image sensor when the emitter 110 is on), a sensor with a separate shutter, or a combination of these. In order to enable the sensors 107 to capture light from specific spots, they can have lenses mounted on the sensor itself, or can have a lens array separate from the sensor, or can have a single common lens mounted between the fluorescent spots and the detectors, or can have a combination of lenses and lens types. Other methods of directing light from the fluorescent spots to specific sensors are to use light guides or to use absorptive or reflective walls to separate the light from individual spots to specific sensors, in which case lenses may not be required. Fluorescence lifetime detection can also be used to measure a single spot or one or more chambers, with or without the need for lenses.Using fluorescence lifetime can have advantages with respect to background light, as much of the background light has a lifetime that is not in the same range as the lifetime of the fluorophore being measured. Other fluorophores with fluorescence lifetimes can be used, where the detector and light source can be turned on and off during the time it takes for the fluorophore to be excited to produce fluorescence, examples being pyrene and 2-aminopurine. Almost all fluorescent probes have a measurable fluorescence lifetime, but if a fluorophore with a longer fluorescence lifetime (on the order of a few nanoseconds) can be used, this simplified detection module can use lower cost components.
[0131] Fig.29 A time diagram 500 showing how fluorescence from a fluorophore is measured when fluorescence lifetime is used to distinguish between excitation light and emission light. The emission light is turned on for a short period of time 501, then the emission light begins to emit 502 and decays. After the excitation light is turned off, the detector can then begin measuring 503 the light 502 before all of the emission light decays. After the detector stops detecting, the entire cycle can then be repeated starting with the emission light turned on. An alternative or additional step to measuring lifetime by turning the emission light on and off is to modulate the emission light and then detect the modulation lag in the sensor light, such as by using a sine wave modulation or a square wave to modulate the excitation light and measuring the phase difference in the detection light, which may require optical filters to separate the emission light and the detection light. One problem with measuring fluorescence of a spot in a liquid environment is that the liquid environment may contain unbound fluorophores that will fluoresce. Therefore, one or more detectors can be used to obtain a reference measurement of the fluorescence of a large amount of the liquid and use a large number of fluorescence readings to get the correct reading from the spot. Another approach is to measure the spot before, at the beginning of a reaction, or during a reaction, thereby detecting changes in fluorescence as the reaction occurs, which will indicate whether the spot has hybridized probe.
[0132] Oligonucleotides labeled with fluorophores with long fluorescence lifetimes can also be attached to surfaces in contact with solution phase isothermal amplification reactions to act as capture probes, which can monitor the progress of the amplification reaction in real time. This can be achieved by labeling the zip code region of the reporter probe with a fluorescent quencher, which will quench the fluorescence of the labeled capture probe upon hybridization. This will eliminate the fluorescent background in the solution. Fluorescence lifetime can be used to detect fluorescence from the labeled capture probe to distinguish between excitation light and emission light.
[0133] Oligonucleotides labeled with long fluorescence lifetime fluorophores attached to the surface may also be contacted with solution phase polymerase chain reaction objects. Solution phase polymerase chain reaction objects may include reporter oligonucleotide probes labeled with quenchers, which are complementary to capture probes on the surface and amplicons in solution phase reactants. Quencher-labeled reporter oligonucleotides may be complementary to amplicons in the internal region of the primer site, so that in the presence of a polymerase with nuclease activity, they are digested or cut during the amplification reaction. In the polymerase extension phase of the reaction, fluorescence lifetime can be used to distinguish between excitation light and emission light, and fluorescence from labeled capture probe points can be detected in real time. As the solution phase reporter oligonucleotide probes are digested during the amplification process, fewer and fewer probes are available for hybridization with the surface and quenching the fluorescence of the labeled capture probes in each cycle. If amplification is ongoing, this will cause the fluorescence of the labeled capture probe points on the surface to increase in each cycle.
[0134] Fig.30 Shown is the signal from an electrochemical detection pad where the cleavage zip code region of a reporter oligonucleotide as a reactant in a nucleic acid amplification reaction in the presence of target has bound to a surface probe labeled 100 copies compared to a negative control.
[0135] How to use
[0136] In some embodiments, the device can be used to detect African swine fever (ASFV), equine herpes virus (EHV), equine infectious anemia virus, equine influenza, porcine epidemic diarrhea virus (PEDv), Salmonella, Escherichia coli, coronavirus, Chlamydia trachomatis, Neisseria gonorrhoeae, human immunodeficiency virus, Treponema pallidum, and any other viral, bacterial, plant or mammalian nucleic acid, recombinant DNA, perform PCR, isothermal amplification methods, or a combination thereof. For example, the device can be used in conjunction with the corresponding parts of USDA document number SOP-DS-0071, revision 03, publication date August 9, 2018, entitled "Preparation, Performance, and Interpretation of the African Swine Fever rPCR Assay on the Applied Biosystems 7500 Real-time PCR System", which is incorporated herein by reference in its entirety.
[0137] The device can be packaged in a clean, sterile sealed foil bag. The micropipette can be packaged in the same bag or in a separate bag. The user can remove the device and micropipette from the bag(s).
[0138] The device can be placed on a flat surface with the screen facing upwards.
[0139] Users can micropipette whole blood or other nucleic acid samples into the inlet ports or wells of the device.
[0140] The user can close the cap tightly, hearing a click and / or feeling a distinct snap as the cap seals and the cap closure tab actuates the device.
[0141] In some embodiments, when the cap is fully depressed and closed, the cap will self-lock and trigger the device to begin testing.
[0142] In some embodiments, after the analysis is complete, the results may be displayed on a screen, the screen may indicate that the results are ready, the results may be transmitted to another device, or the results may be communicated to the user in another manner.
[0143] Closing and pushing the sealed closed cap may trigger pushing down the actuator arm which releases the actuator spring from compression to pierce and penetrate the foil sealed barrel (ie reagent chamber) which may contain, for example, 1 mL of diluent solution (ie liquid reagent).
[0144] The diluent solution (ie, liquid reagent) may include isothermal buffer, MgSO4, MgCl2, betaine, nuclease-free water, or a combination thereof.
[0145] A dilute solution (i.e., liquid reagent) can be passed through the microfluidic chip to mix with the sample and fill the processing chamber. The liquid sample can be mixed with the liquid reagent at a dilution ratio of 1:10. The processing chamber can have dried oligonucleotides, which can be reconstituted and mixed with the mixed sample and liquid reagent.
[0146] The processing chamber can be used for heating. A local heater adjacent to the chamber can heat the mixed sample to about 90 degrees Celsius for about 5 minutes. The processing chamber can have a processing chamber outlet channel, and the processing chamber outlet channel can be sealed by a processing chamber outlet valve; the processing chamber outlet valve can be a wax valve.
[0147] Once heating is complete, the wax valve can be actuated by a separate heater (ie, the process chamber outlet valve heater) to melt the wax and allow sample and liquid reagents from the process chamber to flow through the microfluidic chip and into the next stage.
[0148] The wax valve may be made from paraffin wax (eg, McMaster catalog number: 93955K73).
[0149] The denatured sample can then be passed through a processed sample filter, such as a track-etched membrane filter, to remove inhibitory components. The processed sample filter can be a 5.0 micron track-etched membrane filter (eg, Sterlitech part number: PET5025100).
[0150] The filtered sample can fill the detection chamber for detection.The detection chamber can have a dry enzyme mixture, which can be reconstituted and mixed with the filtered sample.
[0151] The detection chamber can be heated to 60 degrees Celsius by an adjacent heater and kept constant during the optical measurements.
[0152] The detection chamber can be transparent and surrounded by a detection module. The detection module can have two LEDs pointed into the chamber (e.g., KingBright part number: APDA3020VBC / D and KingBright part number APDA3020SYCK / J3-PF) and an optical sensor (e.g., AMS part number: AS7341) that measures the level of fluorescence counts perpendicular to the light beam. A change in counts that resembles an S-shaped curve can be considered a positive result.
[0153] After a 20-minute optical measurement, a microprocessor on the device can run the data through an algorithm to verify whether the sample is positive or negative.
[0154] The display may display the final result. The display may display instructions for use, device status, separation of the liquid sample and / or analysis results. The display may display the results of the analysis of the liquid sample as a result indicator and / or coded text or symbol (e.g., a QR code). The device may delay displaying the results until a code is entered (wirelessly or via a keyboard and / or biometric component on the housing, not shown) and / or a preset amount of time (e.g., 12 hours) has passed since the analysis was completed.
[0155] The method can be performed entirely using a pipette and existing mixing containers and heaters without the need for integrated fluidic devices. For example, the following protocols can be used with or without the disclosed device:
[0156] 1. Isothermal fluorometer Agdia Amplifire (Part No. AFR60400) was used for benchtop protocol detection.
[0157] 2. Preparation of primer / probe mixture:
[0158] a.2.5ul Primer 1 (IDT);
[0159] b. 2.5ul Primer 2 (IDT);
[0160] c. 2.5ul buffer 1 (IDT);
[0161] d. 2.5ul buffer 2 (IDT);
[0162] e. 2.5ul probe (BioSearch); and
[0163] f. 37.5ul nuclease-free water (IDT product number: 11-04-02-01).
[0164] 3. Preparation of dNTP mixture:
[0165] a. 4ul dCTP (TriLink catalog number N-8002-10);
[0166] b. 2ul dTTP (Thermo catalog number: 10297018);
[0167] c. 2ul dATP (Thermo catalog number: 10297018);
[0168] d. 2ul dGTP (Thermo catalog number: 10297018); and
[0169] e. 10ul nuclease-free water (IDT product number: 11-04-02-01).
[0170] 4. Preparation of Reagent 1:
[0171] a. 50ul isothermal buffer (NEB catalog number: B0537S);
[0172] b. 50ul 10x primer / probe mixture;
[0173] c. 50ul 5M betaine (Sigma Aldrich: catalog number: B0300-1VL); and
[0174] d. 215ul nuclease-free water (IDT product number: 11-04-02-01).
[0175] 5. Preparation of Reagent 2:
[0176] a. 5ul MgSO4 (NEB catalog number: B1003S); and
[0177] b. 20ul dNTP mixture.
[0178] 6. Preparation of Enzyme Mix
[0179] a. 12.5ul WarmStart BST 2.0 (NEB catalog number: M0538S); and
[0180] b. 42.5ul BSOBI (NEB catalog number: R0586S).
[0181] 7. Dispense 39ul of reagent 1 into PCR tubes.
[0182] 8. Add 3.9ul of whole blood to the PCR tube containing reagent 1. Pipette up and down to mix.
[0183] 9. Place the PCR tube in a thermal cycler and heat at 95 degrees Celsius for 5 minutes.
[0184] 10. Centrifuge the PCR tube in a microcentrifuge (x7,000g) for 3 minutes.
[0185] 11. Use a pipette to aspirate 18.25ul of the supernatant in the tube and add it to a new PCR tube.
[0186] 12. Add 1.25ul of Reagent 2 to the PCR tube. Pipette dry and mix. Vortex and centrifuge for 20 seconds.
[0187] 13. Place the PCR tube into the Amplifire instrument and wait for the instrument temperature to reach 61 degrees Celsius.
[0188] 14. Add 5.5ul of enzyme mix to the PCR tube and mix well by pipetting up and down (6-8 times). Press Start.
[0189] experiment
[0190]
[0191] Whole blood samples were obtained from pigs experimentally infected with African swine fever and serially diluted with blood from uninfected pigs. The samples were run using the APHIS protocol and the MagMax Kit and compared to the protocol disclosed in this article and the protocol outlined in the bench-scale protocol. The results showed that the protocol disclosed in this article had better sensitivity.
[0192] Example 2
[0193] The user removes the device from a sealed foil bag containing a desiccant pack. The ASFV device contains an electronic ink (E-ink) display that instructs the user to "add sample and close the cap". The device must be placed on a flat surface. The blood sample can be 20uL of whole blood from a pig naturally infected with ASFV. Using a micropipette with a metering of 20uL, the blood sample is dispensed into the inlet hole of the device. The inlet cap attached to the device housing is then closed. The closure of the cap triggers the start of the test by releasing the spring-actuated diluent dispensing and starting the automatic sequence of the circuit board. Liquid dispensing is achieved by a plastic actuator driven by a compression spring piercing the cover of the diluent container containing 700uL of diluent and pushing the diluent into the main fluid chip. The diluent is first pushed through the inlet port where the blood sample is added. The fluid is driven by excess diluent stored in the diluent container and a spring that provides a constant force. The diluent solution and the blood sample are mixed and further pushed into the next chamber of the fluid chip, the processing chamber. The processing chamber is used to heat denature the blood diluent mixture to 95 degrees Celsius for 5 minutes. This chamber contains lyophilized beads containing oligonucleotides specific for ASFV. A flexible circuit board under the fluid chip heats this local area to the target temperature for a period of time. This area of the fluid chip is constructed with heat-sealed aluminum foil on the bottom and a breathable vent membrane on the top to release any air in the fluid path. The outlet channel of the processing chamber is initially closed by a wax valve. After heating the processing chamber for 5 minutes, the wax valve opens by melting the wax at 65 degrees Celsius and allows the liquid to be pushed through the channel into the next chamber. The next chamber contains a 5-micron pore filter membrane to remove blood precipitates and other detection inhibitors from the processed sample solution. The filter membrane also captures the solidified wax in the wax valve. The filtered solution is then pushed into the last chamber of the fluid chip for fluorescence detection. The detection chamber contains another lyophilized bead filled with dNTPS and enzymes for the reaction. This chamber is heated to 60 degrees Celsius and kept constant for 20 minutes. The outside of the chamber has two LEDs pointing to opposite sides of the solution and an optical sensor perpendicular to the light source, which takes multiple measurements per second. One blue LED is used to detect the ASFV target in the blood sample and one red LED is used to detect the internal positive control to verify the accuracy of the device. The device's processor circuit board collects and analyzes optical data using algorithms to detect an S-shaped curve from the optical measurements. After analyzing the detection chamber, the results are displayed on the E-ink display as "positive", "negative", or "invalid". A positive result is detected when the slope change reaches a threshold imposed in the algorithm. A negative result is considered when the optical background noise does not meet this threshold when evaluating the slope change and when the internal positive control provides the expected signal. Invalid results occur when the device is used outside the listed operating conditions, the electronics fail, the battery is discharged, or the internal positive control signal cannot verify a true negative result.
[0194] The blood component separation can also be used in other analytical methods, such as immunoassays, antibody tests, antigen tests, enzyme assays, molecular sequencing, protein sequencing, and other analytical assays and methods for blood or fluid analysis.
[0195] Biological substances other than blood may utilize the separation methods described, either by precipitating the substance in the sample or because blood components may be present in the sample, such as stool samples, urine samples, saliva, tears, vaginal swabs, urethral swabs, nasal swabs, oral swabs, skin swabs, or swabs or exudates from any part of an organism and sample tissue from any part of an organism.
[0196] Each individual variation described and illustrated herein has discrete components and features that may be readily separated or combined with features of any other variation or embodiment. Modifications may be made to adapt a particular situation, material, composition of matter, process, process action or step to the purpose(s), spirit or scope of the present disclosure.
[0197] The methods described herein may be performed in any described order of events and in any described order of events that is logically feasible. In addition, additional steps or operations may be provided, or steps or operations may be eliminated to achieve the desired results.
[0198] In addition, when a range of values is provided, each intervening value between the upper and lower limits of that range and any other stated or intervening value in that range is encompassed within the disclosure. In addition, any optional feature of the variants may be independently set forth and claimed, or combined with any one or more features described herein.
[0199] All prior subject matter (e.g., publications, patents, patent applications, and hardware) mentioned herein are incorporated herein by reference in their entirety, except to the extent that the subject matter may conflict with the present disclosure, in which case the disclosure herein controls. Items referenced are provided solely for their disclosure prior to the filing date of the present application. Nothing herein should be construed as an admission that the present disclosure is not entitled to antedate such material by virtue of prior disclosure.
[0200] References to singular items include the possibility that there are plural identical items. More specifically, as used herein and in the appended claims, the singular forms "a," "an," "said," and "the" include plural referents unless the context clearly dictates otherwise. It should also be noted that the claims can be written to exclude any optional elements. Therefore, this statement is intended to serve as a prerequisite for the use of exclusive terms such as "only," "only," or the use of a "negative" limitation in the recitation of claim elements. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which this disclosure belongs.
[0201] The present disclosure is not intended to be limited to the scope of the particular forms set forth, but is intended to cover alternatives, modifications, and equivalents of the variations or embodiments described herein. In addition, the scope of the present disclosure fully encompasses other variations that may be obvious to those skilled in the art in light of the present disclosure.
Claims
1. A method for separating components of a liquid sample, include: mixing the liquid sample with a reagent, wherein the reagent includes a divalent cation; heating the mixed liquid sample and liquid reagent to 80°C to 99°C; as well as The resulting precipitate was separated from the liquid supernatant. The method according to claim 1 , wherein the reagent is a liquid reagent.
3. The method according to any one of the preceding claims, wherein the reagent is a dry reagent.
4. The method according to any one of the preceding claims, wherein the precipitate is separated from the liquid supernatant by centrifugation.
5. A method according to any one of the preceding claims, wherein the precipitate is separated from the liquid supernatant by forcing the heated mixed liquid sample and liquid reagent through a filter.
6. The method according to any of the preceding claims, wherein the liquid sample comprises a blood sample.
7. The method according to any one of the preceding claims, wherein the divalent cation is magnesium.
8. The method according to any one of the preceding claims, wherein the liquid reagent further comprises betaine.
9. A method according to any one of the preceding claims, wherein the heating is continued for at least 10 seconds.
10. A method according to any one of the preceding claims, wherein heating is at 95°C for 5 minutes.
11. The method according to any one of the preceding claims, further comprising: include: The resulting filtered liquid is exposed to a controlled light frequency and the light frequency emitted, absorbed or transmitted from the resulting filtered liquid is sensed.
12. The method according to any one of the preceding claims, wherein the resulting precipitate removes nucleic acid inhibitors from the liquid supernatant.
13. The method according to any one of the preceding claims, wherein the liquid supernatant is subjected to nucleic acid amplification.
14. The method according to any one of the preceding claims, further comprising: include: The presence of nucleic acids is detected by fluorescence, absorbance, or electrochemical detection.
15. The method according to any one of the preceding claims, wherein the liquid supernatant is subjected to nucleic acid amplification without further dilution.
16. A device for separating components of a liquid sample, include: a reagent chamber containing a reagent including a divalent cation; an inlet port, the inlet port being used to receive the liquid sample; a processing chamber; Process chamber heater; a process chamber outlet valve; Processed sample filter; a detection chamber, wherein the detection chamber is at least partially transparent; and An optical sensor is adjacent to the detection chamber.
17. The device of claim 16, further comprising a light emitter adjacent to the detection chamber.
18. The device of any one of claims 16 or 17, wherein the liquid sample comprises a blood sample.
19. The device of any one of claims 16-18, wherein the divalent cation is magnesium.
20. The device of any one of claims 16-19, wherein the liquid reagent further comprises betaine.
21. The device of any one of claims 16-20, wherein the heating lasts for at least 10 seconds.
22. The device of any one of claims 16-21, further comprising a detection chamber membrane on the detection chamber.
23. The device according to any one of claims 16-22, wherein the reagent is a liquid reagent.
24. The device of any one of claims 16-23, wherein the reagent is a dry reagent.
25. A system for separating components of a liquid sample, include: a reagent chamber containing a reagent including a divalent cation; an inlet port, the inlet port being used to receive the liquid sample; a processing chamber; Process chamber heater; a process chamber outlet valve; Processed sample filter; a detection chamber, wherein the detection chamber is at least partially transparent; an optical sensor adjacent to the detection chamber; and A light emitter is adjacent to the detection chamber.
26. The system of claim 25, wherein the liquid sample comprises a blood sample.
27. The system of any one of claims 25 or 26, wherein the divalent cation is magnesium.
28. The system of any one of claims 25-27, wherein the liquid reagent further comprises betaine.
29. The system of any one of claims 25-28, wherein the heating lasts for at least 10 seconds.
30. The system of any one of claims 25-29, further comprising a detection chamber membrane on the detection chamber.
31. The system of any one of claims 25-30, wherein the reagent is a liquid reagent.
32. The system of any one of claims 25-31, wherein the reagent is a dry reagent.
33. A reporter oligonucleotide that indicates the presence of a target nucleic acid in a sample, wherein a portion of the reporter oligonucleotide acquires the ability to hybridize to a non-target specific oligonucleotide capture probe due to the presence of said target.
34. The reporter oligonucleotide of claim 33, wherein the reporter oligonucleotide comprises a sequence specific to the target nucleic acid, a recognition sequence for a restriction enzyme, a polymerase extension blocker, and a sequence specific to the oligonucleotide.
35. The reporter oligonucleotide of any one of claims 33 or 34, wherein the reporter oligonucleotide has a secondary structure to prevent hybridization with the oligonucleotide capture probe in the absence of target.
36. The reporter oligonucleotide of any one of claims 33-35, wherein the portion of the reporter oligonucleotide that is complementary to the oligonucleotide capture probe is cleaved from the reporter oligonucleotide by reaction with the restriction enzyme.
37. The reporter oligonucleotide of any one of claims 33-36, wherein the oligonucleotide capture probe is attached to an electrochemical detection surface, and wherein the presence of the hybridized portion of the reporter oligonucleotide can be detected electrochemically.
38. A reporter oligonucleotide according to any one of claims 33-37, wherein a portion of the reporter oligonucleotide has a label that can be detected using any of fluorescence, fluorescence lifetime, chemiluminescence, colorimetry, gravimetric methods, cantilever methods or surface plasmon resonance.
39. The reporter oligonucleotide of any one of claims 33-38, wherein the oligonucleotide capture probe is attached to a surface.
40. The reporter oligonucleotide of any one of claims 33-39, wherein the oligonucleotide capture probe is attached to a bead.
41. The reporter oligonucleotide of any one of claims 33-40, wherein the oligonucleotide capture probe is suspended in solution.
42. A reporter oligonucleotide according to any one of claims 33-41, wherein the reporter oligonucleotide is a reactant in a nucleic acid amplification reaction in the presence of a target.
43. The reporter oligonucleotide of any one of claims 33-42, wherein the reporter oligonucleotide is a reactant in an isothermal nucleic acid amplification reaction in the presence of a target.
44. The reporter oligonucleotide of any one of claims 33-43, wherein the isothermal nucleic acid amplification has a thermal step that brings the temperature to a level different from that at which the isothermal reaction occurs.
45. The reporter oligonucleotide of any one of claims 33-44, wherein the reporter oligonucleotide is a reactant in a nucleic acid amplification reaction in the presence of the target.
46. A system for detecting multiple nucleic acid sequences in a chamber by hybridizing a single sequence hit to a specific location on a surface in the container, wherein a single sequence strand or representation of a strand has a fluorescent label using fluorescence lifetime measurement.
47. A system for detecting multiple nucleic acid sequences in a chamber by hybridizing the results of a single sequence to one or more beads in a container, wherein a single sequence strand or representation of a strand has a fluorescent label using fluorescence lifetime measurement.
48. A system for detecting fluorescence in a chamber by using a fluorescent label using fluorescence lifetime measurement.
